Congress Wealth Management LLC DE Increases Stock Position in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Congress Wealth Management LLC DE boosted its position in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 6.1% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 147,715 shares of the company's stock after buying an additional 8,505 shares during the period. Congress Wealth Management LLC DE owned approximately 0.30% of Prestige Consumer Healthcare worth $11,535,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in the company. Kestra Investment Management LLC bought a new position in shares of Prestige Consumer Healthcare during the 4th quarter valued at approximately $27,000. GAMMA Investing LLC raised its stake in Prestige Consumer Healthcare by 18.9% during the fourth quarter. GAMMA Investing LLC now owns 1,383 shares of the company's stock valued at $108,000 after purchasing an additional 220 shares in the last quarter. Blue Trust Inc. lifted its position in Prestige Consumer Healthcare by 24.8% during the fourth quarter. Blue Trust Inc. now owns 2,190 shares of the company's stock valued at $158,000 after purchasing an additional 435 shares during the last quarter. KBC Group NV grew its stake in shares of Prestige Consumer Healthcare by 28.3% in the 4th quarter. KBC Group NV now owns 2,048 shares of the company's stock worth $160,000 after buying an additional 452 shares in the last quarter. Finally, Longboard Asset Management LP bought a new stake in shares of Prestige Consumer Healthcare in the 4th quarter worth about $201,000. Hedge funds and other institutional investors own 99.95% of the company's stock.

Prestige Consumer Healthcare Trading Down 1.2 %

PBH stock traded down $1.01 during midday trading on Friday, reaching $85.03. The company's stock had a trading volume of 33,404 shares, compared to its average volume of 325,416. Prestige Consumer Healthcare Inc. has a 1 year low of $62.35 and a 1 year high of $90.04. The firm has a market capitalization of $4.21 billion, a price-to-earnings ratio of 19.91, a PEG ratio of 2.69 and a beta of 0.46. The stock has a fifty day simple moving average of $83.17 and a two-hundred day simple moving average of $78.89. The company has a debt-to-equity ratio of 0.56, a quick ratio of 2.20 and a current ratio of 3.68.

Remove Ads

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last posted its quarterly earnings results on Thursday, February 6th. The company reported $1.22 EPS for the quarter, topping the consensus estimate of $1.18 by $0.04. Prestige Consumer Healthcare had a net margin of 19.13% and a return on equity of 12.36%. On average, equities research analysts predict that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current year.

Analyst Ratings Changes

Several research analysts recently commented on the company. Canaccord Genuity Group lifted their price target on Prestige Consumer Healthcare from $93.00 to $100.00 and gave the stock a "buy" rating in a research report on Friday, February 7th. Oppenheimer lifted their target price on Prestige Consumer Healthcare from $87.00 to $93.00 and gave the stock an "outperform" rating in a report on Thursday, February 13th. Sidoti lowered Prestige Consumer Healthcare from a "buy" rating to a "neutral" rating and set a $90.00 price target on the stock. in a report on Monday, December 9th. Royal Bank of Canada lifted their price objective on shares of Prestige Consumer Healthcare from $96.00 to $97.00 and gave the stock a "sector perform" rating in a research note on Friday, March 21st. Finally, DA Davidson increased their target price on shares of Prestige Consumer Healthcare from $95.00 to $104.00 and gave the company a "buy" rating in a research note on Friday, February 7th. Three investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $93.33.

Insider Buying and Selling

In other Prestige Consumer Healthcare news, SVP Mary Beth Fritz sold 1,678 shares of the company's stock in a transaction on Monday, March 10th. The stock was sold at an average price of $90.00, for a total value of $151,020.00. Following the completion of the sale, the senior vice president now directly owns 17,157 shares in the company, valued at approximately $1,544,130. This represents a 8.91 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 1.60% of the stock is owned by insiders.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.